Coastlands Capital LP, 10% Owner at Pasithea Therapeutics Corp. (KTTA), bought 100,000 shares at $0.53 ($53K) on 2026-06-17, disclosed to the SEC on 2026-06-22.
Coastlands Capital LP, a 10% holder, acquired 100,000 shares at $0.53, representing the largest insider purchase in the company's history. This accumulation is notable given the stock is currently down 60.19% from its 52-week high and technical analysis suggests a potential support level has formed.
The stock is currently trading at $0.82, a 9.63% gain over the past year but still 60.19% below its 52-week high of $2.06.
The company's forward P/E ratio of -0.52 indicates it is currently unprofitable, and a May 3, 2026, analysis notes the risks associated with investing in unprofitable businesses.
Nothing distinguishes this filing.
| Filing → |
| ADIL | BUY | 2026-07-01 | $65K | — | Filing → |